ABSI CIK: 1672688

Absci Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
273
FY22:
187
FY23:
121
FY24:
134
FY25:
150
(positive)
Change from FY21 to FY25
millions USD
FY21:
153
FY22:
134
FY23:
96.7
FY24:
79.8
FY25:
66.7
Total assets
Change from FY21 to FY25
millions USD
FY21:
426
FY22:
321
FY23:
217
FY24:
214
FY25:
216

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
33.9
FY22:
30.3
FY23:
29.6
FY24:
28.7
FY25:
22.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
26.2
FY22:
16.3
FY23:
11.6
FY24:
5.82
FY25:
4.08
(positive)
Change from FY21 to FY25
millions USD
FY21:
366
FY22:
274
FY23:
176
FY24:
179
FY25:
189
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
426
FY22:
321
FY23:
217
FY24:
214
FY25:
216

All amounts in millions USD Data sources:SEC EDGARTwelve Data